SOURCE: Zannad F et al. NEJM/ESC.
.
© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
SOURCE: Zannad F et al. NEJM/ESC.
.
© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
Clinical question: How effective and safe are apixaban versus rivaroxaban versus warfarin in patients with cirrhosis and nonvalvular atrial fibrillation (AF)? Background: Apixaban, rivaroxaban, and...
Clinical question: Do patients with carotid artery plaque containing detectable microplastics and nanoplastics (MNPs) have a higher risk of myocardial infarction, stroke, or death? Background:...
Clinical question: Does semaglutide improve heart failure (HF) symptoms in patients with obesity-related HF and type 2 diabetes? Background: Obesity-related HF and type 2 diabetes are prevalent...
Clinical question: How common are acute cardiac events among hospitalized older adults (50 years or older) with respiratory syncytial virus (RSV) infection and what are the associated risk...